Investigators at University of Pittsburgh Report Findings in Cancer [The Multifaceted Role of Striatin-interacting Protein 2 (Strip2) In Disease Pathogenesis and Cancer Progression].

A recent report from the University of Pittsburgh explores the role of Striatin-interacting protein 2 (STRIP2) in various cancers, including non-small cell lung cancer, breast cancer, colorectal cancer, and prostate cancer. The research indicates that STRIP2 is overexpressed and amplified in multiple cancer types, leading to poor prognosis. The study suggests that STRIP2 plays a critical role in oncogenic pathways such as proliferation, epithelial-mesenchymal transition, and immune regulation, highlighting its potential as a therapeutic target in cancer treatment. [Extracted from the article]